Biorepositories 2010

Event Information

Start Networking

twitter
twitter
blog
Blog
Linkedin
Linkedin
Opt-In
Opt-In

Download Brochure

Download Brochure
Download Brochure

Send To A Friend

Invite a colleague to join you at this event
Send to Friend

Home

3rd Annual Biorepositories Conference
Your actions today to preserve precious biological samples will significantly impact your future drug development and revenue, and drive forward biospecimen science.
  • Are you looking to build your own biorepository from the ground up? 
  • Are you afraid your biorepository is not adhering to current regulatory and industry guidelines?
  • Do you want the best automation equipment for optimal sample storage practices?
  • Do you want to know how to turn your biobank into a strategic asset?
  • Are you ready to realize the future scientific opportunities proffered by optimal biospecimen storage?
read more


What Makes 2010 Different From The Past?
  • Bring home new insights from 8 all new case studies from GlaxoSmithKline, Pfizer, Takeda, Dow Agrosciences, and more
  • Hear new white paper updates from the IPWG (Industry Pharmacogenomics Working Group) on standards and best practices across the biopharma industry
  • Direct your focus towards the future of biospecimen biobanking with 3 case studies from both pharma and academia on utilizing biobanking best practices to drive forward biospecimen science, biomarker discovery, and drug development
read more

 

2009 Online Documentation

FDA: Biospecimen Quality in Regulatory Submissions Elizabeth Mansfield, PhD, Senior Policy Advisor, Office of In Vitro

Shaping the Biorepository for the New Millennium
Erik Koenig, Senior Manager, Molecular Technologies,
MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY

Ensuring Quality Management of PK Samples from Collection to Archival and Selecting the Right Biorepository for Your Needs
Gina McMullen Sr. PK Research Associate ISIS Pharmaceuticals, Inc.

Testimonials

"The workshops appear to be at a threshold of a new topic in science and business that is only now just being addressed in standardizing the handling of samples."
- Duncan Wallace, Gilead Sciences Inc. read more

Attending Companies
Click here to see attending companies

Keep up with the Future of Biopharma Blog
Meetings Drive Business
To see how leaders use IIR meetings to drive business
companies

Biorepositories 2010 Speaker Podcast:
 Lisa Miranda, President of Biobusiness Consulting
Tracie DeHart, Senior Microbiologist, Dow Agrosciences